Search

everythinglearnresearchcommunity

for

Search:↓

Fractional laser therapy may help regrow hair in alopecia areata.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Perinevoid alopecia can be effectively treated with non-invasive corticosteroids.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

A child with a rare scalp condition regrew hair after treatment.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Antiyeast treatments work better for seborrheic dermatitis than steroids, and other findings include increased skin bacteria under plastic wrap, a nasal cell defect in Staphylococcus aureus carriers, quick resolution of certain skin reactions, high rubber latex allergy in spina bifida patients, and glyceryl monopentadecanoate's effectiveness for male hair loss.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Lupus can look like hair loss from alopecia areata but needs different treatment.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Treatments for melanin disorders exist, but more effective options needed.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

Early diagnosis and treatment can help manage fibrosing alopecia in older women.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Alopesi tedavisinde ilaçlar saç büyümesini teşvik eder ve yeni yaklaşımlar umut vaat eder.

Current methods for assessing bioequivalence of topical drugs are limited and lack standardization.

Nanoformulations improve drug delivery through the skin, reducing side effects and enhancing effectiveness.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.